Darolutamide for prostate cancer: what to know

It is used for non-metastatic castration-resistant prostate cancer and for metastatic castration-sensitive prostate cancer. It is taken alongside treatment that keeps testosterone low; depending on the cancer and treatment plan, docetaxel chemotherapy may also be included.

Androgens can activate receptors inside prostate cancer cells and encourage growth. Darolutamide limits that signal. The terms castration-sensitive and castration-resistant describe whether the cancer is still controlled by lowering testosterone; they do not mean that hormone treatment is stopped.

Your oncology team chooses the combination according to whether cancer has spread, how it has responded to earlier treatment, other medical conditions, and whether chemotherapy is suitable. Blood tests, scans, symptoms and prostate-specific antigen trends help the team judge response and tolerability.

Take darolutamide with food exactly as prescribed and swallow the tablets whole. If a dose is missed, follow the clinic or medicine-leaflet instructions rather than doubling the next dose. Do not stop darolutamide or the accompanying testosterone-lowering treatment without speaking to the oncology team.

Give the pharmacist a complete list of prescriptions, supplements and herbal products because some medicines can change darolutamide levels or be affected by it. Tell the team about kidney or liver problems, heart disease, seizures, new fatigue, rash, falls or persistent pain. Keep scheduled blood tests and review visits even when you feel well.

Contact emergency services for chest pain, sudden shortness of breath, collapse, a new seizure, or signs of a severe allergic reaction such as swelling of the face or throat with breathing difficulty. These symptoms need urgent assessment rather than waiting for the next cancer appointment.

Call the oncology team promptly for a marked change in energy, troublesome rash, worsening weakness, repeated falls, or any new symptom that interferes with eating, drinking, walking or taking medicines. Difficulty passing urine also warrants clinical advice, particularly if no urine passes or lower abdominal pain develops.

Ask which prostate cancer category applies to you, why darolutamide suits that category, and which treatment will continue to suppress testosterone. Clarify whether docetaxel is part of your plan, what monitoring will be used, which side effects should trigger a same-day call, and whom to contact outside clinic hours.

It can also help to ask whether your current medicines interact with darolutamide, how treatment may affect fertility or sexual health, and what to do before dental work, surgery or starting any new medicine.